Electrotherapy device cleared for pain-relief market
Zynex, a maker of medical devices used in pain therapy and stroke rehab, has received 510(k) clearance to sell its NexWave neuromuscular-stimulation product.
In announcing the government’s go-ahead, the company said the new product provides a variety of pain and muscle rehabilitation therapies.
Thomas Sandgaard, the company’s CEO, said the device falls under existing medical billing codes.
Zynex is headquartered in Lone Tree, Colo.
In announcing the government’s go-ahead, the company said the new product provides a variety of pain and muscle rehabilitation therapies.
Thomas Sandgaard, the company’s CEO, said the device falls under existing medical billing codes.
Zynex is headquartered in Lone Tree, Colo.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.